Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

SGMT stock hub

Sagimet Biosciences Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

SGMTis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

476.1M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

SGMT

In the news

Latest news · SGMT

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-38.2

P25 -105.6P50 -46.5P75 -3.1

ROIC-26.6

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All SGMT market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

171

Groups with data

Currency

USD

Showing 171 of 171 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001400118
Company name	Sagimet Biosciences Inc.
Country	United States
Country code	US
Cusip	786700104
Employees	16
Employees Change	2%
Employees Change Percent	14.29
Enterprise value	$363.1M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2023-07-14
Isin	US7867001049
Last refreshed	2026-05-10
Market cap	$476.1M
Market cap category	Small-Cap
Price	$7.71
Price currency	USD
Sector	Healthcare
Sic	2834
Symbol	SGMT
Website	https://www.sagimet.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-10.72%
P/B ratio	2.25x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-51M
Net Income Growth Quarters	2%
Net Income Growth Years	0%
Profit Per Employee	$-3.2M
ROA	-25.7
Roa5y	-29.43
ROCE	-51.08
ROE	-38.2
Roe5y	-46.86
ROIC	-26.6

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	130.97%
EPS Growth Quarters	2
EPS Growth Years	0
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$116.5M
Cash	$113.1M
Current Assets	$116.4M
Current Liabilities	$5.1M
Debt	$78,000
Debt Equity	$0
Equity	$111.4M
Liabilities	$5.1M
Long Term Assets	$78,000
Long Term Liabilities	$0
Net Cash	$113M
Net Cash By Market Cap	$23.74
Net Cash Growth	-28.71%
Net Debt Equity	$-1.01
Tangible Book Value	$111.4M
Tangible Book Value Per Share	$3.42
WACC	24.24

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	22.82
Net Working Capital	$-1.7M
Quick ratio	22.18
Working Capital	$111.3M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-3.17%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	130.84%
200-day SMA	6.75
50-day SMA	5.95
50-day SMA vs 200-day SMA	50under200
All Time High	20.71
All Time High Change	-62.77%
All Time High Date	2024-01-22
All Time Low	1.73
All Time Low Change	345.66%
All Time Low Date	2025-04-07
ATR	0.67
Beta	3.63
Beta1y	1.76
Beta2y	2.83
Ch YTD	30.24
High	7.78
High52	11.41
High52 Date	2025-07-25
High52ch	-32.43%
Low	7.47
Low52	3.08
Low52 Date	2025-05-15
Low52ch	150.33%
Ma50ch	29.6%
Premarket Change Percent	1.05
Premarket Price	$7.72
Premarket Volume	3,276
Price vs 200-day SMA	14.22%
RSI	58.13
RSI Monthly	48.68
RSI Weekly	61.45
Sharpe ratio	1.25x
Sortino ratio	2.51
Total Return	-3.17%
Tr YTD	30.24
Tr1m	51.77%
Tr1w	1.31%
Tr3m	38.92%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	8
Analyst Count Top	3
Analyst Price Target Top	$29
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.36
Operating Income	$-56.9M
Price target	$28.75
Price Target Change	$273
Price Target Change Top	$276

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	59,143,395%
Float Percent	95.78%
Shares Insiders	0.87%
Shares Institutions	23.51%
Shares Out	61,751,807
Shares Qo Q	0.17%
Shares Yo Y	3.17%
Short Float	6.08%
Short Ratio	9.33
Short Shares	5.83

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	3,418,123.3x
Bv Per Share	3.42
Ch1m	51.77
Ch1w	1.31
Ch1y	130.8
Ch3m	38.92
Ch6m	2.53
Change	0.92%
Change From Open	0.78
Close	7.64
Days Gap	0.13
Dollar Volume	7,433,665.9
Earnings Date	2026-05-14
Earnings Time	bmo
EBIT	$-56.9M
EPS	$-1.58
F Score	1
Financing CF	275,000
Fiscal Year End	December
Founded	2,006
Investing CF	4,556,000
Ipr	-51.81
Iprfo	-50.26
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-03-11
Last Report Date	2025-12-31
Last Split Type	Never
Last10k Filing Date	2026-03-11
Ma150	6.42
Ma150ch	20.04%
Ma20	7.03
Ma20ch	9.75%
Net CF	-40,819,000
Next Earnings Date	2026-05-22
Open	7.65
Optionable	Yes
Position In Range	77.42
Post Close	7.71
Postmarket Change Percent	0.01
Postmarket Price	$7.71
Ppne	78,000
Pre Close	7.64
Price Date	2026-05-08
Ptbv Ratio	4.27
Relative Volume	0.28x
Share Based Comp	6,449,000
Tr6m	2.53%
Us State	California
Volume	964,159

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does SGMT pay a dividend?

Capital-return profile for this ticker.

Performance

SGMT stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns SGMT?

Insider, institutional, and short-interest positioning.

Institutional ownership

+23.5%

Float: +95.8% of shares outstanding

Insider ownership

+0.9%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

SGMT momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

58.1

Neutral momentum band

Price vs 200-day MA

+14.2%

50/200-day relationship not available

Beta (5Y)

3.63

More volatile than the market

Sharpe ratio

1.25

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About SGMT

Hub-level FAQ points readers to the deeper analysis pages.

What is the current SGMT stock rating?

Sagimet Biosciences Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full SGMT analysis?

The full report lives at /stocks/SGMT/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for SGMT?

The latest report frames SGMT around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the SGMT page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.